《歐洲藥物科學雜志》是歐洲藥物科學聯(lián)合會(EUFEPS)的官方期刊。該雜志出版的研究報告，評論文章和科學評論的所有方面的藥物科學的重點創(chuàng)新和科學質(zhì)量。編輯歡迎在這個多學科領(lǐng)域的文章，從藥物發(fā)現(xiàn)，藥物交付到藥物開發(fā)。更具體地說，該雜志在藥物化學、藥理學、藥物吸收和代謝、藥物動力學和藥效學、藥物和生物醫(yī)學分析、藥物傳遞(包括基因傳遞、藥物靶向、藥物技術(shù)、藥物生物技術(shù)和臨床藥物評價)等領(lǐng)域發(fā)表報告?？茖W評論和評論文章一般只由編輯邀請或同意?？茖W會議論文集可作為特刊或增刊出版。提交給《日刊》的稿件只有在下列條件下才被接受:(a)它們必須經(jīng)過編輯審查(一般由兩名獨立審稿人審查);(b)它們尚未、也將不會全部或部分發(fā)表在任何其他期刊上;(c)《赫爾辛基宣言》和《東京關(guān)于人類的宣言》的建議以及《歐洲共同體關(guān)于使用實驗動物的公認原則的準則》已得到遵守。

The European Journal of Pharmaceutical Sciences is the official journal of the European Federation for Pharmaceutical Sciences (EUFEPS). The journal publishes research reports, review articles and scientific commentaries on all aspects of the pharmaceutical sciences with strong emphasis on originality and scientific quality. The Editors welcome articles in this multidisciplinary field, ranging from drug discovery, over drug delivery to drug development. More specifically, the Journal publishes reports in medicinal chemistry, pharmacology, drug absorption and metabolism, pharmacokinetics and pharmacodynamics, pharmaceutical and biomedical analysis, drug delivery including gene delivery, drug targeting, pharmaceutical technology, pharmaceutical biotechnology and clinical drug evaluation. Scientific commentaries and review articles are generally by invitation only or by consent of the Editors. Proceedings of scientific meetings may be published as special issues or supplements to the Journal. Manuscripts submitted to the Journal are only accepted on the understanding that (a) they are subject to editorial review (generally by two independent referees); (b) they have not been, and will not be, published in whole or in part in any other journal; (c) the recommendations of the Declarations of Helsinki and Tokyo, for humans, and the European Community guidelines as accepted principles for the use of experimental animals have been adhered to.